Evidence map›Paper›PMID 33543862›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2021

Multiomics-Identified Intervention to Restore Ethanol-Induced Dysregulated Proteostasis and Secondary Sarcopenia in Alcoholic Liver Disease.

Shashi Shekhar Singh, Avinash Kumar, Nicole Welch, Jinendiran Sekar, Saurabh Mishra, Annette Bellar, Mahesha Gangadhariah, Amy Attaway, Hayder Al Khafaji, Xiaoqin Wu and 7 more

Abstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Alcohol Alters Skeletal Muscle Bioenergetic Function: A Scoping Review.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Alcohol and Skeletal Muscle in Health and Disease.Alcohol research : current reviews · 2023
    Review
  18. Article
  19. Article
  20. Side effects of amino acid supplements.Physiological research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shashi Shekhar SinghDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Avinash KumarDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Nicole WelchDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Jinendiran SekarDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Saurabh MishraDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Annette BellarDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Mahesha GangadhariahDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Amy AttawayDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Hayder Al KhafajiDepartment of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA.
Xiaoqin WuDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Vai PathakDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Vandana AgrawalDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Megan R McMullenDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Troy A HornbergerDepartment of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA.
Laura E NagyDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA.
Gangarao DavuluriPennington Biomedical Research Center, Baton Rouge, LA, USA.
Srinivasan DasarathyDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH, USA, dasaras@ccf.org.

Funding

Project Two - Exercise Training Decreases Alcohol Drinking by an FGF21-Dependent MechanismP50AA024333 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Srinivasan Dasarathy · 2016 to 2026
$19.6M
VCU-Atlanta Center for the Childhood Liver Disease Research Network (ChiLDReN)U01DK062470 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI SAUL J. KARPEN · 2005 to 2026
$12.7M
Non Alcoholic Steatohepatitis Clinical Research NetworkU01DK061732 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI Srinivasan Dasarathy · 2002 to 2026
$12.2M
Immersive Training in GlycosciencesK12HL141952 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HASCALL, VINCENT CHARLES, SCHNAAR, RONALD L · 2018 to 2022
$4.8M
Combined Training Program in Digestive Disease SciencesT32DK083251 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI COMINELLI, FABIO, FIOCCHI, CLAUDIO · 2010 to 2025
$3.6M
Mechanotransduction and the Regulation of Skeletal Muscle MassR01AR057347 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI HORNBERGER, TROY A · 2010 to 2019
$3.6M
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD)- Cleveland Clinic Clinical CenterU01AA026976 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Srinivasan Dasarathy, David Streem · 2018 to 2026
$3.2M
Novel mechanism based treatment to improve tissue injury in alcoholic hepatitisR01AA028190 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, NAGY, LAURA E. · 2020 to 2024
$2.8M
Sarcopenia in cirrhosis is mediated by a hyperammonemic stress responseR01DK113196 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, HATZOGLOU, MARIA · 2018 to 2021
$2.3M
Mechanisms of Malnutrition in Cirrhosis with Portosystemic ShuntingR01DK083414 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2011 to 2015
$1.8M
Novel therapeutics for alcoholic hepatitis - Cleveland Translational ComponentU01AA021890 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2012 to 2017
$1.6M
Mechanisms of Malnutrition in Cirrhosis with Portosystemic ShuntingR01GM119174 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2017 to 2020
$1.2M
NHLBI NIH HHS K12 HL141952NHLBI NIH HHS R56 HL141744NIAAA NIH HHS K08 AA028794NIAAA NIH HHS L30 AA027927NIAAA NIH HHS P50 AA024333NIAAA NIH HHS R01 AA028190NIAAA NIH HHS R21 AA022742NIAAA NIH HHS U01 AA021890NIAAA NIH HHS U01 AA026976NIAMS NIH HHS R01 AR057347NIAMS NIH HHS R21 AR071046NIDDK NIH HHS R01 DK083414NIDDK NIH HHS R01 DK113196NIDDK NIH HHS T32 DK083251NIDDK NIH HHS U01 DK061732NIDDK NIH HHS U01 DK062470NIGMS NIH HHS R01 GM119174NIH HHS S10 OD023436NIH (National Institutes of Health) NIH R21 AR 071046, NIH RO1 GM 119174, NIH RO1 DK 113196, NIH RO1 AA 021890, NIH P50 AA024333, NIH UO1 AA 026976, NIH UO1 021890, NIH R56HL141744, NIH 3UO1AA026976, NIH RO1 AR057347, NIH K12HL141952
6 · The paper itself

Abstract

BACKGROUND/

aimsSignaling and metabolic perturbations contribute to dysregulated skeletal muscle protein homeostasis and secondary sarcopenia in response to a number of cellular stressors including ethanol exposure. Using an innovative multiomics-based curating of unbiased data, we identified molecular and metabolic therapeutic targets and experimentally validated restoration of protein homeostasis in an ethanol-fed mouse model of liver disease.

methodsStudies were performed in ethanol-treated differentiated C2C12 myotubes and physiological relevance established in an ethanol-fed mouse model of alcohol-related liver disease (mALD) or pair-fed control C57BL/6 mice. Transcriptome and proteome from ethanol treated-myotubes and gastrocnemius muscle from mALD and pair-fed mice were analyzed to identify target pathways and molecules. Readouts including signaling responses and autophagy markers by immunoblots, mitochondrial oxidative function and free radical generation, and metabolic studies by gas chromatography-mass spectrometry and sarcopenic phenotype by imaging.

resultsMultiomics analyses showed that ethanol impaired skeletal muscle mTORC1 signaling, mitochondrial oxidative pathways, including intermediary metabolite regulatory genes, interleukin-6, and amino acid degradation pathways are β-hydroxymethyl-butyrate targets. Ethanol decreased mTORC1 signaling, increased autophagy flux, impaired mitochondrial oxidative function with decreased tricarboxylic acid cycle intermediary metabolites, ATP synthesis, protein synthesis and myotube diameter that were reversed by HMB. Consistently, skeletal muscle from mALD had decreased mTORC1 signaling, reduced fractional and total muscle protein synthesis rates, increased autophagy markers, lower intermediary metabolite concentrations, and lower muscle mass and fiber diameter that were reversed by β-hydroxymethyl-butyrate treatment.

conclusionAn innovative multiomics approach followed by experimental validation showed that β-hydroxymethyl-butyrate restores muscle protein homeostasis in liver disease.

Indexed as

Liver Diseases, AlcoholicProteostasis DeficienciesSarcopeniaAnimalsBiomarkersCell LineDisease Models, AnimalEthanolFemaleGene Expression RegulationGenomicsHydroxybutyratesMiceSignal TransductionBiomarkersEthanolHydroxybutyratesAutophagy; Mitochondria; Pathway-analyses; Protein synthesis; Proteomics; Transcriptomics

Identifiers

PMID33543862
PMCPMC8195260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.